Literature DB >> 20605220

A longitudinal analysis of posttraumatic stress disorder symptoms and their relationship with Fear and Anxious-Misery disorders: implications for DSM-V.

David Forbes1, Ruth Parslow, Mark Creamer, Meaghan O'Donnell, Richard Bryant, Alexander McFarlane, Derrick Silove, Arieh Shalev.   

Abstract

This paper examined the hypothesis that PTSD-unique symptom clusters of re-experiencing, active avoidance and hyperarousal were more related to the fear/phobic disorders, while shared PTSD symptoms of dysphoria were more closely related to Anxious-Misery disorders (MDD/GAD). Confirmatory factor and correlation analyses examining PTSD, anxiety and mood disorder data from 714 injury survivors interviewed 3, 12 and 24-months following their injury supported this hypothesis with these relationships remaining robust from 3-24 months posttrauma. Of the nine unique fear-oriented PTSD symptoms, only one is currently required for a DSM-IV diagnosis. Increasing emphasis on PTSD fear symptoms in DSM-V, such as proposed DSM-V changes to mandate active avoidance, is critical to improve specificity, ensure inclusion of dimensionally distinct features and facilitate tailoring of treatment.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20605220     DOI: 10.1016/j.jad.2010.05.005

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  18 in total

1.  An Investigation of Depression, Trauma History, and Symptom Severity in Individuals Enrolled in a Treatment Trial for Chronic PTSD.

Authors:  Michele Bedard-Gilligan; Jeanne M Duax Jakob; Lisa Stines Doane; Jeff Jaeger; Afsoon Eftekhari; Norah Feeny; Lori A Zoellner
Journal:  J Clin Psychol       Date:  2015-04-20

2.  Chronic nicotine differentially alters spontaneous recovery of contextual fear in male and female mice.

Authors:  Jessica M Tumolo; Munir Gunes Kutlu; Thomas J Gould
Journal:  Behav Brain Res       Date:  2018-01-05       Impact factor: 3.332

3.  Cannabinoid type 1 receptor availability in the amygdala mediates threat processing in trauma survivors.

Authors:  Robert H Pietrzak; Yiyun Huang; Stefani Corsi-Travali; Ming-Qiang Zheng; Shu-fei Lin; Shannan Henry; Marc N Potenza; Daniele Piomelli; Richard E Carson; Alexander Neumeister
Journal:  Neuropsychopharmacology       Date:  2014-05-12       Impact factor: 7.853

Review 4.  Transdiagnostic impairment of cognitive control in mental illness.

Authors:  Lisa M McTeague; Madeleine S Goodkind; Amit Etkin
Journal:  J Psychiatr Res       Date:  2016-08-05       Impact factor: 4.791

5.  Personality and the latent structure of PTSD comorbidity.

Authors:  Mark W Miller; Erika J Wolf; Annemarie Reardon; Ashley Greene; Shani Ofrat; Scott McInerney
Journal:  J Anxiety Disord       Date:  2012-03-14

Review 6.  The anxiety spectrum and the reflex physiology of defense: from circumscribed fear to broad distress.

Authors:  Lisa M McTeague; Peter J Lang
Journal:  Depress Anxiety       Date:  2012-04       Impact factor: 6.505

Review 7.  Post-traumatic stress disorder and cardiometabolic disease: improving causal inference to inform practice.

Authors:  K C Koenen; J A Sumner; P Gilsanz; M M Glymour; A Ratanatharathorn; E B Rimm; A L Roberts; A Winning; L D Kubzansky
Journal:  Psychol Med       Date:  2016-10-04       Impact factor: 7.723

Review 8.  Understanding heterogeneity in PTSD: fear, dysphoria, and distress.

Authors:  Lori A Zoellner; Larry D Pruitt; Frank J Farach; Janie J Jun
Journal:  Depress Anxiety       Date:  2013-06-12       Impact factor: 6.505

9.  The Evolving Construct of Posttraumatic Stress Disorder (PTSD): DSM-5 Criteria Changes and Legal Implications.

Authors:  Lori A Zoellner; Michele A Bedard-Gilligan; Janie J Jun; Libby H Marks; Natalia M Garcia
Journal:  Psychol Inj Law       Date:  2013-12-01

10.  Dimensional structure and correlates of posttraumatic stress symptoms following suspected acute coronary syndrome.

Authors:  Jennifer A Sumner; Ian M Kronish; Robert H Pietrzak; Daichi Shimbo; Jonathan A Shaffer; Faith E Parsons; Donald Edmondson
Journal:  J Affect Disord       Date:  2015-07-29       Impact factor: 4.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.